Nasdaq IPOs

Gores Metropoulos II, the second blank check company formed by Dean Metropoulos and The Gores Group, raised $400 million by offering 40 million units at $10. Each unit will consist of one share of common stock and one-fifth of a warrant, exercisable at $11.50. The company is led

JOFF Fintech Acquisition, a blank check company targeting the financial services industry and FinTech, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units

Longeveron, a Phase 2 biotech developing cellular therapies for aging-related conditions, filed on Tuesday with the SEC to raise up to $30 million in an initial public offering. Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging

Longeveron, a Phase 2 biotech developing cellular therapies for aging-related conditions, filed on Tuesday with the SEC to raise up to $30 million in an initial public offering. Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging

Signify Health, which provides a platform for in-home healthcare services and value-based payment programs, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. Signify Health is a leading healthcare platform that leverages analytics, technolo

FoxWayne Enterprises Acquisition, a blank check company targeting biotechnology and telemedicine in North America, raised $50 million by offering 5 million units at $10. Each unit consists of one share of common stock and one whole warrant, exercisable at $11.50. The trust i

Oyster Enterprises Acquisition, a blank check company led by executives from hedge fund Alden Global targeting media, tech, and other industries, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of one warrant,

Biophytis, a French Phase 2 biotech developing therapies for COVID-related complications and age-related diseases, filed on Tuesday with the SEC to raise up to $15 million in an initial public offering. The company is currently listed on the Euronext Growth Paris (ALBPS). It

Itiquira Acquisition, a blank check company targeting growth sectors in Brazil, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. The New York, NY-based company plans to raise $200 million by offering 20 million units at $10. Each unit will

ZIM Integrated Shipping Services, an Israeli container shipping company with over 320K TEU capacity, announced terms for its IPO on Tuesday. The Haifa, Israel-based company plans to raise $306 million by offering 17.5 million shares at a price range of $16 to $19. At the midpoin

NexImmune, a Phase 1/2 biotech developing T cell immunotherapies for cancer, filed on Tuesday with the SEC to raise up to $86 million in an initial public offering. NexImmune is developing a novel approach to immunotherapy designed to employ the body's own T cells to generate a

Adagene, a Phase 1 biotech developing antibody cancer immunotherapies in China, filed on Tuesday with the SEC to raise up to $125 million in an initial public offering. Adagene is a platform-driven, clinical-stage biopharmaceutical company involved in the discovery and developme

Speculative areas of the market are not just red hot, they are white hot.

Cloopen Group Holding, which provides cloud-based communication services in China, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. In terms of 2019 revenue, Cloopen Group operates the largest multi-capability cloud-based communications so

Vinci Partners Investments, an alternative asset manager in Brazil, announced terms for its IPO on Tuesday. The Rio de Janeiro, Brazil-based company plans to raise $236 million by offering 13.9 million shares at a price range of $16 to $18. At the midpoint of the proposed range,

Decarbonization Plus Acquisition II, the fourth blank check company formed by Riverstone targeting businesses advancing global decarbonization, raised the proposed deal size for its upcoming IPO on Tuesday. The Menlo Park, CA-based company now plans to raise $350 million by offe

Shoals Technologies Group, a leading US provider of electrical balance-of-system products for solar projects, announced terms for its IPO on Tuesday. The Portland, TN-based company plans to raise $1.0 billion by offering 50 million shares (79% insider) at a price range of $19 to

Ortho Clinical Diagnostics, a Carlyle-backed global provider of in vitro diagnostic products, announced terms for its IPO on Tuesday. The Raritan, NJ-based company plans to raise $1.5 billion by offering 70 million shares at a price range of $20 to $23. At the midpoint of the pr

Qualtrics International, an experience management software provider being spun out of SAP, announced terms for its IPO on Tuesday. The Provo, UT-based company plans to raise $1.2 billion by offering 49.2 million shares at a price range of $22 to $26. The company plans to raise a

Decipher Biosciences, which provides genomic testing products for urologic oncology, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. Decipher's prostate cancer genomic testing products, Decipher Biopsy and Decipher RP, provide information